Magical VC Setting FiO2 100-PEEP 5-RR 15-TV 400: In Volume Control (VC) mode, initial settings such as FiO2 at 100%, PEEP at 5 cm H2O, a respiratory rate of 15 breaths per minute, and a tidal volume of 400 mL provide a foundational approach for the management of mechanically ventilated patients. These parameters serve as starting points and must be finely adjusted based on the patient's specific needs and responses, with ongoing monitoring to ensure optimal outcomes.
MV without Referring to PBW: While minute ventilation (MV) calculations ideally utilize predicted body weight (PBW) for accuracy, emergency clinical scenarios might necessitate quick estimations without immediate access to detailed PBW tables. Under such circumstances, a rough MV can be quickly calculated based on the patient's weight: approximately 5 liters per minute for a 50 kg patient, 6 liters for a 60 kg patient, and 7 liters for a 70 kg patient. These preliminary estimates are vital for initial ventilator setup, requiring subsequent adjustments as more information becomes available or as the patient's condition evolves.
Lung Condition Without Cdyn but Quickly Using Plateau Pressure: Dynamic compliance (Cdyn), a detailed measure of lung condition, typically considers values greater than 50 mL/cm H2O as normal, while lower values suggest potential ARDS, necessitating further diagnostics like chest X-rays. However, measuring Cdyn involves time-consuming inspiratory and expiratory holds. A quicker clinical alternative is to observe the plateau pressure. If the plateau pressure, based on an accurate MV computation per PBW, remains below 30 cm H2O, it suggests that the lungs are likely not severely compromised, indicating that the current ventilatory support is within safe limits and avoiding undue lung stress. If the difference between the peak pressure and plateau pressure is less than 5 cm H2O, it may indicate that the lung condition is within an acceptable range.
PEEP Setting Adjustments Based on Chest X-ray Findings: A clear chest X-ray typically warrants a PEEP of 5 cm H2O, while mild, moderate, and severe infiltrations might necessitate settings of 10, 15, and 20 cm H2O, respectively. However, maintaining PEEP below 12 cm H2O is generally advisable to avoid decreasing cardiac output and blood pressure:
FiO2 | 100 | 90 | 80 | 70 | 60 | 50 | 40 | 30 |
---|---|---|---|---|---|---|---|---|
PEEP | 12 | 11 | 10 | 9 | 8 | 7 | 6 | 5 |
Monitoring with Trend Feature - Airway Resistance Associated with Peak Pressure and Lung Condition with Plateau Pressure: When airway resistance increases, it is typically observed as a rise in peak pressure in the ventilator, while plateau pressure remains stable, particularly noticeable in Volume Control (VC) mode. Absence of an upper limit for peak pressure can cause significant increases. Conditions like pneumonia can escalate both peak and plateau pressures, necessitating rigorous monitoring. Utilizing the "Trend" feature of ventilators is crucial as it helps monitor these pressures over 24 hours, facilitating informed clinical decisions. If peak pressure rises while plateau pressure remains stable, this suggests increased airway resistance. Conversely, an increase in both peak and plateau pressures, or just plateau pressure, can indicate deteriorating lung compliance, potentially requiring further assessments such as a chest X-ray.
Use of Ventilator Loop Features: In ventilator management, the loop feature is an invaluable tool for comparing the current respiratory status against specific points in the past, helping identify changes and trends in a patient's condition. Modern ventilators, such as Servo ventilators, often feature a button labeled "Freeze," "Reference," or "Hold" that allows clinicians to compare the current loop with those from previous time points. By pressing this button, you can capture the current graph and overlay it with a graph from a previous time, facilitating a visual comparison of respiratory mechanics. This is particularly useful for evaluating changes when symptoms like sputum obstruction are present.
The Lower Inflection Point (LIP) on the pressure-volume loop provides crucial insights into the patient's respiratory mechanics. If the LIP shifts slightly to the right, it often correlates with airway obstruction, such as the presence of sputum, indicating that higher pressure is needed to overcome the resistance and begin inflating the lungs. Conversely, if the LIP remains the same or appears swollen (wider), it may suggest intrinsic lung issues, such as reduced lung compliance seen in conditions like ARDS or fibrosis, where the lung tissue is stiffer and harder to inflate. Increased airway resistance typically causes a rightward shift of the LIP without necessarily causing it to swell. Understanding these differences helps clinicians make informed decisions about ventilator management and patient care.Note: It is crucial to customize all ventilator settings to the individual needs of the patient, considering their specific medical conditions, responsiveness to initial settings, and changes in their clinical status. This guide provides a foundational framework and should be utilized in conjunction with the latest clinical guidelines and under the supervision of experienced clinicians.
For a male:
PBW = 50 + 0.91 × (Height − 152.4)
PBW = 50 + 0.91 × (170 − 152.4)
= 50 + 0.91 × 17.6
= 50 + 16.016
= 66.016 kg
(rounded to 66.0 kg)
Using 6 mL/kg:
VT = PBW × 6 = 66.0 × 6 = 396 mL
(approx. 396 mL)
Mosteller Formula:
BSA = √((Height × Weight) / 3600)
BSA = √((170 × 80) / 3600)
= √(13600 / 3600)
= √3.7778
≈ 1.944 m²
(rounded to 1.94 m²)
For a male in Version 1.1:
MV = 3.5 × BSA
= 3.5 × 1.94
= 6.79 L/min
(rounded to 6.8 L/min)
f = MV / (VT in liters)
VT in liters = 396 mL ÷ 1000 = 0.396 L
RR = 6.8 L/min ÷ 0.396 L
≈ 17.17 breaths/min
(rounded to 17 breaths/min)
The PBW is a critical factor in setting ventilator parameters, particularly for determining tidal volume. Calculating PBW based on height helps prevent lung injury by guiding the adjustment of ventilator settings.
For Males:
PBW (kg) = 50 + 0.91 × (Height in cm − 152.4)
For Females:
PBW (kg) = 45.5 + 0.91 × (Height in cm − 152.4)
Explanation: PBW is determined by height, not actual weight, to optimize ventilator settings such as tidal volume, which helps in preventing ventilator-induced lung injury.
Tidal volume is calculated based on PBW to ensure lung protection, especially in conditions such as ARDS.
VT = PBW (kg) × Desired Tidal Volume per kg
Common Range: 6–8 mL/kg PBW for lung-protective ventilation.
Example Calculation: VT = PBW × 6 mL/kg
Explanation: Lower tidal volumes, generally around 6 mL/kg PBW, are typically used to reduce the risk of lung injury in patients.
To calculate the updated Minute Ventilation (MV) and the corresponding Respiratory Rate (RR), we follow these steps:
Step 1: Calculate Body Surface Area (BSA) using the Mosteller formula
The Mosteller formula is given by:
$$ BSA = \sqrt{\frac{\text{height (cm)} \times \text{weight (kg)}}{3600}} $$
For example, if a patient’s height is 170 cm and weight is 70 kg:
$$ BSA = \sqrt{\frac{170 \times 70}{3600}} \approx 1.76 \text{ m}^2 $$
(rounded to 2 decimal places)
Step 2: Compute Minute Ventilation (MV) based on BSA
MV is now derived from BSA using gender-specific multipliers:
For males: $$ MV = 3.5 \times BSA \quad \text{(L/min)} $$
For females: $$ MV = 4.0 \times BSA \quad \text{(L/min)} $$
For instance, for a male patient with a BSA of 1.76 m²:
$$ MV \approx 3.5 \times 1.76 \approx 6.16 \text{ L/min} $$
Step 3: Determine the Required Respiratory Rate (RR)
First, convert the Tidal Volume (VT) from milliliters (mL) to liters (L):
$$ VT (\text{L}) = \frac{VT (\text{mL})}{1000} $$
Then, calculate the respiratory rate required to achieve the computed MV:
$$ RR = \frac{MV}{VT (\text{L})} $$
For example, if the selected VT is 400 mL (i.e., 0.4 L) and MV is 6.16 L/min:
$$ RR \approx \frac{6.16}{0.4} \approx 15.4 \text{ breaths per minute} $$
Step 4: Output
The computed values of MV and RR are then displayed to guide clinicians in adjusting ventilator settings, ensuring that the patient receives the appropriate ventilation based on their body size and chosen tidal volume.
The respiratory rate can be determined from the minute ventilation and tidal volume:
f = V̇E / VT
Explanation: Balancing RR and VT is key in ensuring proper ventilation while minimizing the risk of ventilator-induced complications.
BSA is used in a variety of clinical calculations, such as dosing and metabolic assessments, and provides a more accurate representation of body size.
Mosteller Formula:
BSA (m²) = sqrt(Height (cm) × Weight (kg) / 3600)
Du Bois Formula:
BSA (m²) = 0.007184 × Height (cm)0.725 × Weight (kg)0.425
This calculator estimates essential ventilator parameters in either Volume Control (VC) or Pressure Control (PC) mode using the following steps:
We then round the result to one decimal place. PBW is used because actual body weight can overestimate lung size in obesity or fluid overload scenarios. Using PBW helps avoid excessive tidal volumes.
Once we have a target VT, the calculator solves for respiratory rate: \[ \text{RR} = \frac{\text{MV}}{\text{VT}_{\text{in liters}}} \]
Vt |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
Flow Shape | |||
Safety Vt |
Trigger |
Vt |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
PS (NL: 5–15 cmH₂O) |
Rise time (NL: 0.1–0.4 s) |
Flow Shape |
|
Trigger |
Cycle |
P control |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
Rise time |
|||
Safety Vt |
Trigger |
P control |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
PS (NL: 5–15 cmH₂O) |
Rise time (NL: 0.1–0.4 s) |
||
Trigger |
Cycle |
Volume Control (VC)
VC Ventilator Settings
|
Pressure Control (PC)
PC Ventilator Settings
|
Effective lung protection strategies are essential in mechanical ventilation, particularly when managing conditions such as Acute Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pulmonary Disease (COPD).
Plateau Pressure Management: It is crucial to keep the peak inspiratory pressure (PIP) below 40 cm H2O to mitigate the risk of barotrauma and volutrauma. For ARDS patients, ensuring the plateau pressure remains at or below 30 cm H2O is imperative. The driving pressure — defined as the difference between plateau pressure and Positive End-Expiratory Pressure (PEEP), also known as 'Pressure above PEEP' — should not exceed 15 cm H2O to prevent lung injury. This approach, supported by findings from Marcelo B.P. Amato et al. (NEJM, 2015), demonstrates that maintaining the driving pressure below 15 cm H2O significantly enhances survival outcomes by minimizing lung stress and reducing the risk of ventilator-induced lung injury (VILI).
Considerations for Managing Airflow Obstruction in COPD and Complicated Cases: In conditions like COPD where severe airflow obstruction is prevalent, it may be necessary to maintain a peak inspiratory pressure above 50 cm H2O to ensure adequate ventilation, especially since the plateau pressure is likely to stay below 30 cm H2O. This helps prevent hypoventilation and maintains sufficient oxygen delivery. However, special caution is necessary when COPD is complicated by conditions like new onset pneumonia, where unrestricted peak pressures can significantly increase plateau pressures, elevating the risk of lung injury. It is essential to meticulously monitor and adjust ventilator settings to keep the plateau pressure within safe limits.
Tidal Volume Adjustment: To prevent lung overdistension and minimize the risk of VILI, a lower tidal volume of 4 to 6 mL/kg of predicted body weight (PBW) is recommended for ARDS patients. Patients without ARDS can typically tolerate a standard tidal volume ranging from 6 to 8 mL/kg of PBW. (Generally, a lung condition is considered stable if the plateau pressure remains below 30 cm H2O, even when a tidal volume of 400 mL is used. This stability indicates that the lungs are not being overdistended and that the mechanical ventilation is within safe limits to support the patient's respiratory needs without causing additional harm.)
The table below provides a structured overview of common ventilator modes, arranged from those relying primarily on machine-driven parameters to those granting greater patient autonomy. Each mode lists the primary control variable, mandatory settings (with typical ranges where applicable), and additional adjustable parameters. The ranges and values are considered guidelines and may vary depending on clinical judgment and individual patient needs.
Mode | Primary Control Variable | Mandatory Settings | Additional Settings |
---|---|---|---|
VC (Volume Control) | Volume |
|
|
PC (Pressure Control) | Pressure |
|
|
PRVC (Pressure Regulated Volume Control) | Volume-targeted, Pressure-limited |
|
|
SIMV VC + PS | Volume (Mandatory) & Pressure (Spont.) |
|
|
SIMV PC + PS | Pressure (Mandatory) & Pressure (Spont.) |
|
|
PS (Pressure Support) | Pressure (Spontaneous) |
|
|
% Pressure Support is for intubated or non-intubated patients, depending on their needs. |
|||
ST (Spontaneous/Timed, NIV) | Pressure (with backup) |
|
|
BiPAP (NIV) | Pressure (Spontaneous) |
|
|
CPAP | Pressure (Spontaneous) |
|
|
SV (Spontaneous Ventilation) | Patient-driven |
|
|
ST & SV Integrated | Pressure (with backup) |
|
|
Ventilator modes such as ST (Spontaneous/Timed, Non-Invasive Ventilation) and SV (Spontaneous Ventilation) provide respiratory support tailored to various clinical needs. These modes range from offering a combination of spontaneous and timed breaths to facilitating entirely patient-driven breathing efforts. Modern ventilators often integrate ST and SV modes to enhance flexibility and adaptability in managing patient care, particularly in non-invasive applications.
ST mode, also known as Spontaneous/Timed Non-Invasive Ventilation (NIV), delivers patient-initiated spontaneous breaths combined with ventilator-delivered timed breaths. It is intended for patients capable of breathing spontaneously but who require additional support to maintain adequate ventilation and oxygenation.
SV mode relies entirely on the patient’s own respiratory drive, providing minimal or no machine assistance. It is suitable for patients who are largely breathing independently but may benefit from occasional support to reduce the work of breathing.
Modern ventilators that integrate ST and SV modes offer notable advantages, ensuring that respiratory support is appropriately matched to changing patient conditions.
Enhanced Flexibility: Integrating ST and SV allows tailoring of respiratory support to the patient’s evolving status. For example, a patient may benefit from more controlled assistance at one point and require greater freedom for spontaneous breathing at another. This dynamic adjustment helps maintain optimal ventilation with minimal manual intervention.
Optimized Patient Comfort and Compliance: By providing both timed mandatory breaths and opportunities for spontaneous ventilation, integrated modes align with natural breathing patterns, often improving patient comfort and reducing the perception of reliance on a machine. Enhanced synchrony between the patient and ventilator may also decrease sedation requirements and facilitate a more rapid recovery.
Improved Clinical Outcomes: Integrated ST and SV modes support gradual weaning from mechanical ventilation by offering appropriate assistance as respiratory function improves. They can adapt to changes in a patient’s respiratory mechanics, ensuring consistent and adequate support without excessive intervention.
Comprehensive Support for Various Clinical Scenarios: These integrated modes are beneficial in a wide range of clinical situations, from acute respiratory distress to chronic respiratory conditions. The ability to deliver ST and SV non-invasively expands their applicability to patients who may not tolerate invasive ventilation, improving overall patient management strategies.
Written on December 12th, 2024
Practically speaking, a significant advantage of Volume Control (VC) ventilation is its ability to allow a single clinician to manage multiple patients simultaneously, especially in scenarios that require interventions like sputum suction, which can decrease minute ventilation (MV). In such situations, VC automatically increases the peak pressure to maintain the predetermined tidal volume (TV), giving clinicians additional flexibility and time to manage other tasks. Conversely, Pressure Control (PC) ventilation maintains a fixed pressure, which does not automatically adjust in response to changes in patient conditions, such as diminished TV due to airway obstruction. This characteristic necessitates a more immediate and direct response from clinical staff to ensure patient safety and effective ventilation.
Pressure Control (PC) ventilation offers several significant benefits due to its decelerating flow characteristics. Firstly, it is highly recommended for neonates because it reduces the risk of complications. Secondly, PC ventilation typically results in lower peak inspiratory pressures (PIP), which can minimize the risk of lung injury. The decelerating flow pattern in PC ventilation results in lower PIP because it better accommodates the natural compliance and resistance of the lungs. In contrast, the constant flow pattern in Volume Control (VC) ventilation can lead to higher PIP due to the inability to adjust to varying airway resistance dynamically. Additionally, an increase in mean airway pressure (MAP) can reduce dead space and enhance oxygenation. Furthermore, PC improves patient-ventilator synchrony and reduces the work of breathing (WOB), thereby decreasing the likelihood of the patient 'fighting' the ventilator. This is particularly advantageous as PC allows for flexible adjustment of the inspiration time, contributing to more natural breathing patterns that better meet the dynamic needs of the patient.
Plateau Pressure: In Volume Control (VC) mode, plateau pressure is not directly visible during regular ventilation cycles. It must be measured using an inspiratory pause, where airflow is briefly halted at the end of inspiration to allow pressures within the lung to equalize, giving a true measure of plateau pressure. Also, during the T-pause, which is the pause time during VC mode, the plateau pressure is estimated effectively due to the cessation of airflow, which allows for pressure equilibration across the pulmonary system, reflecting the pressure exerted by the ventilator against the lung compliance. In Pressure Control (PC) mode, since the ventilator delivers a preset pressure and maintains it throughout the inspiratory phase, the peak pressure is effectively the plateau pressure.
Pressure Regulated Volume Control (PRVC) integrates the precision of Volume Control (VC) with the protective features of Pressure Control (PC), forming a unique and dynamic approach to mechanical ventilation. In this mode, a preset tidal volume is targeted, much like in VC, but the delivery method adapts characteristics of PC by adjusting the inspiratory pressure automatically on a breath-to-breath basis. This adaptability ensures the set volume is delivered with the minimum necessary pressure, enhancing patient safety by reducing the risk of barotrauma. The key settings include not only the tidal volume but also an adjustable inspiratory pressure (capped at an upper limit to prevent lung injury), respiratory rate, inspiratory time, and positive end-expiratory pressure (PEEP), which aids in maintaining alveolar stability and improving oxygenation.
The operational flexibility of PRVC becomes particularly advantageous when managing patients with variable lung mechanics. If a drop in the delivered tidal volume is detected, the system initially applies a volume-type strategy, automatically adjusting to a pressure-type mode if the volume shortfall persists. This ensures the intended tidal volume is maintained even under changing physiological conditions. As the patient's lung mechanics stabilize and tidal volume recovers, the system responsively lowers the peak pressure. This dynamic adjustment not only optimizes gas exchange and lung protection but also minimizes the risk of ventilator-induced lung injuries, making PRVC an essential tool in modern respiratory care, particularly in scenarios where both volume consistency and pressure mitigation are critical. (Additionally, PRVC employs a decelerating flow waveform, similar to PC, enhancing gas exchange and matching ventilation closely to the patient's needs.)
Drawbacks: If the patient's airway resistance increases, the peak pressure cannot rise as rapidly or effectively as in PC mode due to the inherent limitations of PRVC. PRVC adjusts pressure gradually, both increasing and decreasing it slowly. This slower adjustment can lead to delays in reaching the necessary inspiratory pressure during sudden changes in the patient's airway resistance or compliance, making PRVC less responsive in acute situations where rapid pressure adjustments are necessary. Additionally, PRVC's dependence on accurate real-time respiratory data means that sudden changes in the patient's condition or data errors might prevent timely adjustments, potentially leading to inappropriate ventilatory support. Noteworthily, during procedures such as sputum suctioning, the removal of airway obstructions can suddenly reduce airway resistance. PRVC might respond by delivering a higher tidal volume than intended before recalibrating, risking overdistension of the lungs. This potential for increased tidal volume underscores the importance of careful monitoring during such procedures.
Ventilator pressure modes are categorized into controlled and support modes, each tailored to different patient needs. In controlled mode, the ventilator autonomously delivers breaths at preset times and volumes, which is essential for patients who are unconscious or unable to breathe voluntarily. This mode ensures that the patient receives adequate ventilation without relying on their respiratory effort, leading to generally seamless synchrony between the patient and the ventilator due to the absence of patient-initiated breathing efforts.
Conversely, support mode is designed to work in harmony with the patient's own respiratory efforts. It dynamically adjusts variables such as the inspiratory to expiratory (I:E) ratio, inspiratory time, tidal volume, and trigger sensitivity based on the patient's initiated breaths. This mode is particularly beneficial for conscious patients who are capable of voluntary breathing but still require assistance to maintain adequate ventilation. However, achieving synchrony in support mode can be challenging, as the ventilator must finely tune its responses to closely match the timing and intensity of the patient's spontaneous breaths.
Specific considerations arise within these modes, especially concerning Pressure Control (PC) and Pressure Support (PS) ventilation. In PC mode, patients with conscious and voluntary breathing may face synchrony challenges because the fixed pressure delivery might not align perfectly with their natural breathing patterns. This misalignment can lead to discomfort or inefficiency in ventilation support.
In contrast, PS mode often proves more suitable for conscious patients who can initiate breaths. This mode allows for a more natural interaction with the ventilator, which can significantly improve both synchrony and comfort by adapting the ventilation support more closely to the patient's actual respiratory needs. The inspiratory time in PS mode isn't set by the clinician but is instead determined by the patient's inspiratory effort and the cycle-off criteria, typically based on a percentage of peak inspiratory flow. This approach makes the inspiration time more dynamic and patient-driven, reflecting their current respiratory status and contributing to a more personalized ventilation strategy.
Overall, support mode is crucial for patients who are capable of participating in their own breathing yet require assistance to achieve or maintain adequate ventilation. This mode's flexibility helps accommodate individual respiratory patterns and reduces the work of breathing, making it a preferred option for patients in the process of recovering respiratory function.
Adjusting inspiratory settings for better outcomes in mechanical ventilation involves meticulous management of the dynamics between Pressure Control (PC) and Pressure Support (PS) ventilation modes. In PC ventilation, manual adjustment of the inspiratory time (Ti) is crucial to maintain patient-ventilator synchrony. Typically, longer Ti settings are well-tolerated during sleep, but adjustments may be necessary when a patient awakens and becomes more active. Changes in the breathing pattern, often observable on the pressure graph as an upward trend at the end of inspiration, indicate the patient's attempt to exhale while the ventilator continues to deliver air. Reducing Ti in these instances helps align the ventilator support with the patient's natural desire to breathe more shallowly or exhale, thereby reducing the risk of patient-ventilator asynchrony, often referred to as "fighting the ventilator."
In PS ventilation, the inspiratory cycle-off setting is critical. This setting determines when the ventilator ceases inspiratory pressure support and transitions to expiration, based on a predefined percentage of peak inspiratory flow. Typically, the inspiratory cycle-off is set to terminate inspiration at about 25% of the peak inspiratory flow. Adjustments to this setting are necessary when patients exhibit signs of discomfort or asynchrony, such as trying to exhale while still in the inspiratory phase. Decreasing this percentage to around 15% can allow the ventilator to switch to the expiratory phase sooner, thus reducing the risk of breath stacking and enhancing comfort. This adjustment better synchronizes the ventilator with the patient's breathing efforts, particularly if the patient completes their inhalation quickly or feels that the breaths are too long. Conversely, increasing the cycle-off percentage to around 50% prolongs the time the ventilator provides support during inhalation. This can be beneficial if the patient feels they are not getting enough air before the ventilator cycles off, as it allows more complete inhalation according to the patient's needs.
However, in PS mode, adjusting Ti is not an option since it is inherently designed to be patient-driven. The duration of inspiration is determined by the patient's inspiratory effort and the cycle-off setting, rather than a fixed time set by the clinician. This design emphasizes the supportive nature of PS ventilation, giving patients greater control over their breathing patterns, which is especially vital for those with varying levels of respiratory drive. This approach allows inspiration time to be more dynamic and patient-driven, reflecting their current respiratory needs and efforts, and enhances overall patient comfort and ventilator efficiency.
Double triggering is a significant issue in mechanical ventilation, particularly in Pressure Support (PS) and Pressure Control (PC) modes, with a higher occurrence in PS. This phenomenon arises when the ventilator's sensitivity settings fail to align with the patient's actual respiratory demands, or if the inspiratory time set by the device does not synchronize with the patient's natural breathing pattern. Such misalignments can lead to a scenario where a patient initiates a second breath while the first is still being completed, potentially disrupting both patient comfort and the efficiency of the ventilation process.
In PS mode, the ventilator responds to the patient's breathing efforts, and if these efforts trigger the ventilator prematurely during the inspiratory cycle, double triggering may occur. This typically happens if the patient attempts to breathe in again before the machine has completed the cycle, which ideally should transition into expiration. In PC mode, although the ventilators are programmed with preset inspiratory times to mitigate this issue by strictly controlling the breathing cycles, mismatches with the patient's natural respiratory rhythm can still lead to synchronization problems and subsequent double triggering.
To manage and prevent double triggering effectively, it is crucial to ensure that the ventilator settings are meticulously adjusted to the patient's current respiratory status. This includes fine-tuning the sensitivity settings and inspiratory times to better match the patient's natural breathing patterns, thus minimizing the risk of premature initiation of a second breath.
Effective management of ventilator settings, particularly trigger sensitivity, is essential, especially in the presence of leaks. The default setting for flow trigger sensitivity is typically +2, which detects changes in flow rate to initiate ventilation in response to patient-initiated respiratory efforts. To minimize the risk of auto-triggering due to a leak, it may be necessary to adjust this setting to -2 or lower. Settings in negative values use pressure triggers, which are more precise in detecting actual decreases in pressure, thus ensuring a more accurate response to genuine respiratory efforts and reducing false triggers.
For neonatal patients, who exhibit unique respiratory dynamics, a higher sensitivity setting of +5 may be required. This adjustment ensures that the ventilator can effectively detect the subtle respiratory efforts typical in neonates, which might not activate standard sensitivity settings.
In scenarios involving patients with Acute Respiratory Distress Syndrome (ARDS), the severely compromised lung function results in rapid exhalation phases, making Pressure Support Ventilation (PSV) unsuitable. PSV depends heavily on the patient's spontaneous breathing, which may be insufficient or unstable in ARDS cases. Consequently, Pressure Control Ventilation (PCV) is generally preferred as it provides better control over the breathing cycle with fixed pressure delivery, aiding in synchronizing ventilation with the patient's respiratory needs.
However, even in PCV, mismatches between the set inspiratory times and the patient's natural breathing rhythm can lead to double triggering — where the ventilator delivers two breaths in rapid succession without allowing for a full exhalation in between. Managing these cases may necessitate clinicians to adjust the trigger sensitivity to make the ventilator less responsive to minor respiratory efforts, increase the volume settings for more complete breaths, or use sedation to moderate the patient's spontaneous breathing efforts, thereby enhancing overall control over ventilation.
In Pressure Control (PC) mode, rapid increases in pressure at the onset of inspiration can sometimes lead to disruptions in the ventilator's pressure graph, which may appear as abrupt changes or instabilities. Such occurrences can compromise the smooth delivery of ventilation and potentially affect patient comfort. To address this issue, it's essential to adjust the 'T insp rise' setting, which controls the rate at which pressure increases during the inspiratory phase.
Typically, if this setting is at zero (or off), the pressure rise is immediate and steep, leading to what might be perceived as an abrupt start to inspiration. Incrementally adjusting this setting by 5% or 10% allows for a more gradual and controlled pressure increase. This modification helps smooth out the initial pressure transition, thereby stabilizing the pressure graph at the beginning of inspiration. Such adjustments not only enhance the mechanical performance of the ventilator but also improve patient-ventilator synchrony and reduce potential stress on the patient's respiratory system.
In Pressure Control (PC) mode, "PC above PEEP" refers to the pressure set above the baseline Positive End-Expiratory Pressure (PEEP) during the inspiratory phase, and this value is equivalent to the driving pressure. According to the study by Marcelo B.P. Amato et al. (NEJM, 2015), driving pressure (ΔP) is a critical factor associated with survival in patients with acute respiratory distress syndrome (ARDS). The study found that lower driving pressures, achieved by adjusting ventilator settings to avoid increases in peak inspiratory pressure (PIP) while optimizing PEEP, were strongly linked to improved survival rates.
Active Inspiration: Protecting lung integrity is critical, as highlighted by studies such as "Driving Pressure and Survival in the Acute Respiratory Distress Syndrome" by Marcelo B.P. Amato et al. (NEJM, 2015) and "Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome" by The Acute Respiratory Distress Syndrome Network (NEJM, 2000). However, strict adherence to these guidelines might lead to insufficient breathing, potentially causing double triggering if patients inhale more than the set tidal volume. To mitigate this, clinicians may consider increasing the tidal volume, adjusting trigger sensitivity, or sedating the patient to decrease spontaneous efforts. Raising the trigger level can enhance ventilator response to patient-initiated breaths, while reducing it helps prevent double triggering. Modifications to ventilator alarm settings, such as the low PEEP alarm, are also often necessary. In Pressure Control (PC) mode, inspiratory time (Ti) is generally set between 0.8 to 1.25 seconds but may be shortened to minimize ventilator conflict. Unlike PC mode, Pressure Support (PS) mode does not allow direct control over Ti, thus incrementally adjusting the "End Inspiration" or "Esens" settings from 30% to 50% can assist in better managing breath termination timing.
Active Expiration: Challenges during expiration, particularly with high Positive End-Expiratory Pressure (PEEP) settings, increase work of breathing (WOB), potentially causing discomfort and leading to non-compliance with ventilation. Shortening the expiratory time in PC mode can effectively address these issues. In PC mode, adjusting the expiratory time primarily involves altering the inspiratory time (Ti) and the respiratory rate (RR), as these settings will indirectly affect how long the expiratory phase lasts. For example, decreasing the Ti from 1.2 seconds to 0.8 seconds and maintaining a consistent respiratory rate will naturally extend the expiratory phase. In Pressure Support (PS) mode, expiratory time adjustment differs since inspiratory time is typically patient-driven. Adjusting the "cycling off" criteria, for instance, setting it to terminate inspiration when the flow decreases to 25% of the peak flow rate, will typically shorten the inspiratory phase and potentially increase the expiratory time.
Managing Leaks: Leaks in Volume Control (VC) mode particularly pose challenges, as they can prevent the ventilator from delivering the set tidal volume accurately. This shortfall in delivered volume can destabilize vital signs and may prompt incorrect ventilator adjustments. "End Inspiration" settings may need to be adjusted upwards (e.g., from 30% to 50%), and "Trigger Pressure" should be set to a less sensitive level (ranging from -10 to -20). Regular checks, such as ensuring proper ET tube cuff pressurization and verifying ventilator integrity with a test lung, are essential for identifying equipment-related issues. If leaks persist, increasing minute ventilation (MV) may temporarily resolve issues until more definitive solutions like reintubation or manual bagging are executed.
Biased Flow: Biased flow maintains a continuous stream of air through the mechanical ventilation system, aiding in keeping airways open and detecting spontaneous breathing efforts. Typically set at 2 liters per minute, biased flow comprises a significant part of the total ventilation volume. For example, out of a total of 9 liters, 7 liters are ventilator-delivered, and 2 liters are biased flow. An active inhalation of 1.6 liters (or 80% of the biased flow) by a patient indicates effective inspiration. For smaller or weaker patients, increasing the biased flow (from 2L to 3L or 4L) ensures even minimal efforts are recognized, thus easing their breathing work. However, too high a setting may induce auto-triggering, where minor disturbances are mistakenly interpreted as breathing attempts. Adjusting sensitivity settings can help mitigate auto-triggering, ensuring the ventilator supports only genuine respiratory efforts.
Neurally Adjusted Ventilatory Assist (NAVA) represents a progressive form of mechanical ventilation that optimizes the synchronization between the ventilator and the patient by leveraging the electrical activity of the diaphragm (EAdi). This technology allows the ventilator to respond dynamically to the patient's breathing needs, ensuring that assistance is provided in direct correlation with their respiratory effort. This method not only enhances comfort but also aligns precisely with the patient's natural respiratory drive, crucial for those who can breathe spontaneously but require additional support due to conditions like respiratory failure or challenges in weaning from mechanical support.
The functionality of NAVA hinges on the continuous monitoring of Edi, which acts as the primary trigger for ventilatory assistance. When a patient initiates a breath, the resulting electrical activity of the diaphragm prompts the ventilator to deliver pressure proportionate to this signal, ceasing as the signal diminishes. This responsive system adapts to the patient's breathing needs in real-time, offering a level of support directly correlated to their respiratory muscle effort, thereby mitigating the risks of over- or under-ventilation and enhancing comfort.
The principle of NAVA lies in its ability to detect and utilize the diaphragm's electrical signals as the direct driver for ventilatory assistance. The ventilator adjusts its support based on real-time changes in EAdi, providing a tailored respiratory aid that prevents the common pitfalls of conventional ventilation, such as asynchrony or mismatched timing and intensity of support. This responsiveness to the patient's own respiratory signals makes NAVA particularly advantageous for patients with varying respiratory drive and those susceptible to discomfort with traditional mechanical ventilation methods. However, the efficacy of NAVA can be compromised in patients with conditions that impede the generation or detection of accurate EAdi signals, such as severe diaphragmatic dysfunction, certain neuromuscular disorders, or obstructive esophageal pathologies that prevent proper catheter placement.
NAVA is particularly beneficial in conditions like Acute Respiratory Distress Syndrome (ARDS) in adults and Respiratory Distress Syndrome (RDS) in neonates. It's also indicated in cases of pulmonary hypertension and scenarios requiring detailed assessment of respiratory activity, such as in central hypoventilation syndrome. However, its application is limited by conditions that affect the diaphragm's ability to generate reliable Edi signals, such as neuromuscular disorders, severe diaphragmatic dysfunction, or esophageal anomalies, which might impede the placement or function of the necessary esophageal catheter.
Setting up a NAVA system requires meticulous initial adjustments to ensure optimal patient support. These settings include establishing the NAVA level, which is calculated by the formula NAVA level x (Edi max - Edi min) + PEEP, and determining the trigger sensitivity. The chosen NAVA level, expressed in cmH2OμV, should aim for a target Edi range of 5-20 μV, adjusted based on observed Edi max values to either enhance or reduce ventilatory support.
Clinically, NAVA has shown to significantly improve patient-ventilator synchrony, reducing the risks associated with mechanical ventilation such as ventilator-induced lung injury. By supporting the natural breathing pattern of the patient rather than overriding it, NAVA facilitates a more physiological form of respiratory support, which can lead to better outcomes in the weaning process and overall patient comfort. Its capability to adjust support based on the patient's immediate respiratory muscle output distinguishes it from other assisted modes like Pressure Support Ventilation (PSV), which may not accurately align support with patient effort.
The real-world application of NAVA, especially in complex clinical scenarios, underscores its significant benefits. Studies have documented improved outcomes in diverse patient populations, including adults with acute respiratory conditions and neonates experiencing respiratory distress (Beck et al., 2009; Breatnach et al., 2010). The ability to maintain effective ventilation despite challenges such as air leaks — common in both invasive and non-invasive forms of ventilation — further demonstrates NAVA's robustness (Beck et al., 2009). Its adaptability extends to non-invasive applications, where it can be used with nasal prongs or masks, allowing for a smoother transition from invasive to non-invasive support and potentially reducing the need for higher pressures typically required in conventional ventilation settings (Makker et al., 2020).
When considering the various modes of mechanical ventilation with spontaneous patient breathing — Spontaneous Timed (ST), BiPAP (Bilevel Positive Airway Pressure), BiVent/APRV (Airway Pressure Release Ventilation), Volume Support (VS), Pressure Support (PS), and CPAP (Continuous Positive Airway Pressure) — it's essential to understand both their operational characteristics and the freedom they afford to patients. Each mode requires specific parameters to be set, ensuring optimal ventilation and patient comfort during respiratory support:
In understanding these modes, it's crucial to note that PS mode with 'PS above PEEP' set at zero essentially functions as CPAP, offering continuous positive airway pressure without additional support during inspiration. This equivalence underscores the versatility of PS mode, adapting its function based on settings to meet patient needs. BiPAP, on the other hand, provides variable pressure support during both inhalation and exhalation, offering enhanced ventilation assistance compared to CPAP or PS alone. However, despite its efficacy, BiPAP may feel more restrictive to patients due to its dual-pressure levels. Conversely, CPAP, whether delivered independently or through PS mode, offers continuous support with less complexity, potentially affording patients a greater sense of freedom in their breathing.
When considering freedom to breathe, PS mode stands out as it allows patients to initiate breaths spontaneously and breathe at their own pace. This mode synchronizes with the patient's respiratory effort, providing additional support when needed, while still allowing for variability in breathing rates and patterns. ST mode, while offering partial ventilatory support, imposes fixed intervals for mandatory breaths, which may feel somewhat restrictive compared to the flexibility of PS mode. BiPAP, with its dual-pressure levels, offers tailored support during both inspiration and expiration but may feel more constraining due to its preset parameters. CPAP, whether provided independently or through PS mode, offers continuous positive airway pressure without additional support during inspiration, providing a stable environment for breathing but potentially lacking the adaptability of PS mode.
BiVent/APRV is notable for its innovative ventilation strategy that emphasizes spontaneous breathing across the entire respiratory cycle. This mode operates by maintaining a high baseline airway pressure to optimize oxygenation and alveolar recruitment, while periodically dropping to a lower pressure to allow for CO2 elimination without disrupting the patient's natural breathing attempts. The high pressure phase supports the alveoli continuously, which is critical for patients experiencing severe respiratory distress. In contrast, the brief, controlled lower pressure phase acts like a sigh, aiding in more effective CO2 removal. This mode's ability to allow spontaneous breathing throughout its cycle offers a significant improvement in patient comfort compared to more traditional, restrictive methods.
Volume Support (VS), on the other hand, provides a blend of controlled and supportive ventilation, ideal for patients who are capable of initiating breaths but require assistance in achieving consistent tidal volumes due to varying respiratory muscle strength or lung compliance. Once a patient initiates a breath in VS mode, the ventilator adjusts the pressure dynamically to deliver a predetermined tidal volume. This adaptability ensures adequate ventilation while permitting the patient to control the timing and frequency of breaths, thereby reducing fatigue and promoting a more natural breathing pattern. Unlike modes such as Pressure Support (PS) or BiPAP, VS not only supports the breath initiated by the patient but also guarantees the delivery of a specific volume, adjusting pressure as needed on a breath-by-breath basis to maintain consistent minute ventilation.
Weaning patients from mechanical ventilation is a critical step in their recovery, marking the transition from artificial support back to natural breathing patterns. Typically, humans breathe using negative pressure, where the diaphragm creates a vacuum that draws air into the lungs. In contrast, mechanical ventilation employs positive pressure to push air into the lungs, which can lead to complications such as barotrauma from excessive air pressure and inadequate gas exchange due to low tidal volumes. To mitigate these issues, sedation often facilitates controlled mechanical ventilation with two primary modes: Volume Control (VC), where tidal volume is precisely regulated, and Pressure Control (PC), which adjusts "PC above PEEP" to ensure consistent lung inflation.
As patients stabilize, ventilator settings transition to support modes that allow more spontaneous breathing efforts. Pressure Support (PS) aids each breath initiated by the patient by maintaining "PS above PEEP," while Continuous Positive Airway Pressure (CPAP) maintains a constant pressure to keep the alveoli open, supporting natural lung function but not directly assisting the breathing effort. A notable challenge with support modes like PS is their inability to control the respiratory rate (RR), which can result in apnea if the patient's spontaneous efforts are insufficient.
Transitioning from Controlled Mandatory Ventilation (CMV) to Assisted/Control Mandatory Ventilation (ACMV) is significant, allowing the start of inspiration to be patient-initiated rather than ventilator-initiated, granting more autonomy in the breathing process. For patients requiring intermittent assistance, Synchronized Intermittent Mandatory Ventilation (SIMV) provides mandatory breaths as a backup, set by the SIMV rate, which defines the frequency of controlled breathing. Crucially, if there is an absence of spontaneous patient breathing, the system reverts from ACMV to CMV, ensuring continuous ventilation. However, between controlled breaths, PS can be activated to provide necessary support.
Moreover, transitioning from PS to CPAP involves shifting the control from "PS above PEEP" to a mode where only PEEP is provided, allowing patients under CPAP to utilize negative pressure for breathing. Significantly, if the inspiration strength in PS is set to zero, it effectively transitions the operation to CPAP, emphasizing passive support through maintained PEEP without additional pressure support. This phase is critical as it encourages patients to engage their respiratory muscles more actively, vital for successful weaning.
Assessing Readiness for Ventilator Weaning Using RSBI and P 0.1: To determine if a patient is ready for weaning from mechanical ventilation, two key measures are often evaluated: the Rapid Shallow Breathing Index (RSBI) and the P 0.1 or Occlusion Pressure. The RSBI is calculated by dividing the respiratory rate (RR) by the expiratory tidal volume (VTe) measured in liters. An RSBI value less than 105 breaths per minute per liter is considered indicative of a patient's readiness for weaning. This index, measured during a spontaneous breathing trial, helps assess the patient's workload of breathing, providing a quantitative basis for evaluating their ability to breathe independently.
Additionally, the P 0.1, which is the negative pressure exerted by the patient in the first 100 milliseconds of an occluded airway, is another crucial measure. A P 0.1 value between 1 to 2 cm H2O suggests a lower respiratory drive, which can indicate that the patient may be ready for weaning. This measure provides insight into the patient's respiratory effort and capacity to maintain adequate breathing without ventilatory support. Both the RSBI and P0.1 are essential in providing a comprehensive assessment of a patient's potential to successfully transition off mechanical ventilation.
Predicts the success of weaning from mechanical ventilation. An RSBI ≤ 105 breaths/min/L is considered an indicator of readiness for weaning.
RSBI = f / VT
Successful weaning from mechanical ventilation requires a holistic evaluation of the patient's clinical status. While the Rapid Shallow Breathing Index (RSBI) is a valuable predictor, it should be considered alongside other critical factors to ensure the patient is ready for spontaneous breathing without mechanical support.
An RSBI of 105 or less is widely accepted as an indicator that the patient may be ready for weaning. This threshold suggests that the patient is likely to tolerate spontaneous breathing effectively.
The patient should exhibit stable blood pressure and heart rate without the need for high doses of vasopressors. Hemodynamic stability indicates that the cardiovascular system can support the increased workload associated with independent breathing.
A PaO₂/FiO₂ ratio greater than 150–200 with minimal positive end-expiratory pressure (PEEP ≤ 5 cm H₂O) demonstrates sufficient gas exchange capacity. This level of oxygenation suggests the lungs can function adequately without extensive ventilatory support.
The patient should be awake, alert, and cooperative. Adequate cognitive function ensures that the patient can manage airway protective reflexes and participate in the weaning process.
A strong cough and the ability to clear secretions are essential. The patient should manage secretions without excessive assistance to reduce the risk of aspiration and respiratory complications.
Secretions should be minimal and easily handled without frequent suctioning. Excessive secretions can obstruct airways and impede successful weaning.
Blood gas analyses should indicate stable respiratory function without significant acidosis (PaCO₂ near the normal range). This stability suggests the patient can maintain adequate ventilation independently.
The patient should require low levels of ventilatory support, indicating readiness to breathe without assistance. Parameters such as low PEEP and low inspiratory pressures are favorable signs.
Adequate nutritional status and electrolyte balance support muscle strength and endurance, which are crucial for sustained spontaneous breathing.
The patient should be free from active infections or fever, as these conditions can increase metabolic demands and respiratory workload, potentially hindering the weaning process.
Emotional and psychological factors can impact respiratory function. The patient should be assessed for anxiety or other psychological conditions that might affect weaning success.
A comprehensive assessment involving a multidisciplinary team is essential to evaluate these factors thoroughly. Each patient's unique clinical context should guide the decision-making process, ensuring that weaning is conducted safely and effectively with close monitoring for any signs of distress or failure.
Managing a patient with ALS experiencing dyspnea necessitates a nuanced approach to both immediate and long-term respiratory support strategies. An effective initial strategy often includes adjusting the Inspiratory Positive Airway Pressure (IPAP) in Spontaneous/Timed (ST) mode, for example, increasing it from 13 to 15 cm H2O. This adjustment can enhance alveolar ventilation by increasing the tidal volume, potentially alleviating symptoms of dyspnea and reducing the patient's respiratory effort. Such strategic management is essential in addressing progressive neuromuscular conditions like ALS, where muscle weakness can intensify over time, escalating the patient's respiratory workload.
If the patient's dyspnea persists and there is an inclination to remove the ventilator, it might indicate a conflict during inspiration when the patient attempts to exhale. In such scenarios, it is crucial to consider adjusting or increasing the "Cycle" setting of the ST mode from the current 25% gradually upwards. This adjustment can help synchronize the ventilator more closely with the patient's natural breathing cycle, potentially reducing the sensation of fighting the ventilator and improving comfort.
Continuous assessment is crucial to determine if further adjustments or a switch in ventilation mode might offer additional benefits. In cases where adjustments to IPAP alone are insufficient for managing symptoms effectively, or when concerns arise regarding patient comfort and ventilator synchrony, exploring other modes such as BiPAP or CPAP may be warranted.
BiPAP is particularly beneficial due to its capability to independently control both IPAP and EPAP, allowing for customized support during both inhalation and exhalation phases. Unlike ST mode, which primarily focuses on maintaining a minimum number of breaths per minute with less flexibility, BiPAP facilitates dynamic adjustments that can more precisely respond to the patient's varying respiratory needs throughout the day or as their condition changes. This refined approach to respiratory support is especially advantageous in ALS, where patients may experience fluctuating respiratory efforts.
Furthermore, BiPAP can enhance patient-ventilator synchrony by independently and precisely adjusting IPAP and EPAP. This adjustment improves synchrony with the patient's natural breathing cycle, potentially reducing asynchrony and increasing comfort — critical factors for patients who can still initiate breaths but whose respiratory strength may vary. The versatility of BiPAP extends to periods of sleep or varying levels of respiratory muscle fatigue, making it an optimal choice for maintaining comfort and effective ventilation across different states of patient activity and rest.
Pressure Support (PS) mode offers another viable option for patients capable of initiating breaths independently but who require assistance to maintain adequate ventilation. PS mode supports the patient's breathing effort by providing a preset level of pressure support during inhalation, terminated based on the patient's inspiratory flow, thus facilitating a more natural breathing pattern. This mode significantly enhances patient-ventilator synchrony and comfort, particularly beneficial for conscious patients with fluctuating respiratory drive.
Conversely, Continuous Positive Airway Pressure (CPAP) maintains a constant pressure throughout the respiratory cycle. This mode might not suit ALS patients requiring active assistance with inhalation due to muscle weakness. CPAP is generally more appropriate for patients who can maintain adequate spontaneous breathing efforts and primarily need support in keeping their airways open.
Ultimately, the decision to adjust IPAP within ST mode or to transition to another mode such as BiPAP or PS should be driven by ongoing evaluations of the patient's respiratory status, including blood gas analyses and symptom assessment. Regular re-evaluation and close monitoring are essential to ensure that the ventilatory support continues to meet the evolving needs of the ALS patient, striving to achieve an optimal balance of adequate ventilation, patient comfort, and minimal respiratory effort. This comprehensive approach ensures that respiratory management is both effective and adaptable, providing tailored support that evolves with the patient's condition.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
In managing respiratory distress in patients using BiPAP ventilation, specific adjustments are essential for those showing signs of hypoventilation and CO2 retention. Typically, these patients demonstrate reduced tidal volumes (Vt) of 150-250 mL, with arterial blood gas (ABGA) analyses indicative of mild respiratory acidosis, typically with a pH slightly below the normal range of 7.35-7.45, and elevated PCO2 slightly above the normal range of 35-45 mmHg. Bicarbonate levels may also be at the upper end of the normal range (22-28 mEq/L), indicating renal compensation. Additionally, an elevated PO2 well above the normal range for room air (75-100 mmHg) suggests the use of supplemental oxygen therapy, which is crucial for managing hypoxemia but requires careful monitoring to avoid complications associated with hyperoxia.
Rationale for Increasing IPAP: An increase in IPAP, for example from 13 to 15 cm H2O, is strategically implemented to enhance alveolar ventilation and improve CO2 clearance. This intervention is essential as it directly increases tidal volume, promoting deeper breaths that not only help in recruiting more alveoli for gas exchange but also effectively eliminate excess CO2.
Reasoning for Lowering Oxygen Supply: Even with stable SpO2 levels above 92%, reducing supplemental oxygen is crucial to prevent oxygen toxicity and hyperoxia, which could suppress respiratory drive — particularly harmful in conditions predisposing to CO2 retention. Adjusting oxygen delivery to maintain SpO2 just above 92% ensures sufficient oxygenation without compromising the patient's inherent respiratory efforts, thereby supporting natural respiratory mechanisms and enhancing overall respiratory function.
Necessity of Manual Adjustment of IPAP: Despite the dynamic capabilities of BiPAP machines to adjust IPAP and EPAP, manual intervention is often required. Automatic adjustments might not always perfectly align with rapidly changing or unique clinical situations due to limitations in preset algorithms. Manually increasing IPAP allows healthcare providers to fine-tune ventilatory settings based on real-time patient responses and specific ventilation goals, ensuring that the therapeutic approach is precisely tailored to achieve optimal outcomes. This level of customization is crucial for effectively managing acute respiratory distress and provides significant advantages over more rigid modes like ST, which are less adaptable to patient-specific needs.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Home Ventilator Application Status - Chronic CO2 retention and respiratory acidosis - Compensatory metabolic alkalosis - December 22, 2023: BiPAP initiated - December 29, 2023: Due to diaphragmatic dysfunction, home ventilator initiated in SIMV-PS mode Tidal Volume (TV): 300–350 mL Inspiratory Pressure (Pi): 10–15 cmH2O Respiratory Rate (RR): 16 breaths/min - February 2024: Home ventilator adjusted (SIMV mode) Pressure (Pr): 13 cmH2O PEEP: 5 cmH2O RR: 15 breaths/min O2: 1 L/min - March 25, 2024: Changed to PSV mode Measured TV: ~300 mL Pressure Support (Pr): 12 cmH2O PEEP: 5 cmH2O RR: 15 → 14 breaths/min - November 8, 2024: PSV mode continued Measured TV: ~300 mL Pr: 12 cmH2O PEEP: 5 cmH2O RR: 14 breaths/min
The patient has chronic CO2 retention and a compensatory metabolic alkalosis, indicating a long-term respiratory failure scenario. Initial noninvasive management (BiPAP) was followed by a transition to a home ventilator setup due to diaphragmatic dysfunction. Over time, the ventilator mode evolved from SIMV with pressure support to PSV, reflecting changes in clinical strategy and attempts to balance stable support with partial patient-driven ventilation. Ultimately, the patient has maintained stability on a PSV configuration without further reductions in pressure support.
Documented Settings: BiPAP (Bilevel Positive Airway Pressure) initiated, but no exact pressures recorded.
Typical Variables Required:
Commentary: BiPAP provides two distinct pressure levels. At this stage, it was likely chosen to noninvasively support ventilation, reduce CO2 levels, and alleviate work of breathing. Precise IPAP and EPAP values would be necessary to fully reproduce the initial setup. The missing data here—such as exact pressure levels and O2—suggests incomplete information.
Documented Settings: SIMV-PS mode: TV ~300–350 mL, Pi 10–15 cmH2O, RR 16 (PEEP and exact FiO2/O2 unknown)
Typical Variables Required for SIMV-PS:
Commentary: Transitioning to SIMV suggests a need for more structured ventilatory support. Some parameters (PEEP, FiO2) are not documented here, making it hard to fully replicate the initial SIMV setup. The mention of Pi (Inspiratory Pressure) suggests a pressure-limited or pressure-supported component for spontaneous breaths.
Documented Settings: SIMV: Pr 13 cmH2O, PEEP 5 cmH2O, RR 15, O2 1 L/min
Typical Variables for SIMV-PS:
Commentary: By February, the documentation is more complete: a defined pressure support level (Pr 13 cmH2O) and PEEP (5 cmH2O) are stated, along with RR and O2 flow. This reflects a refinement in the ventilation strategy. The patient is still receiving partial mandatory support (SIMV) along with pressure support for spontaneous breaths. Although O2 is given as 1 L/min, the exact FiO2 remains unreported; still, this information is more sufficient for reproduction compared to December 29, 2023.
Documented Settings: PSV mode: Measured TV ~300 mL, Pr 12 cmH2O, PEEP 5 cmH2O, RR from 15 to 14
Typical Variables Required for PSV:
Commentary: Switching to PSV reduces mandatory breaths, relying on the patient’s inspiratory effort. Pressure Support (12 cmH2O) and PEEP (5 cmH2O) remain key settings. The measured tidal volume (~300 mL) and recorded RR (14) show patient-driven ventilation within supported parameters. Additional variables (exact FiO2, alarm settings) are not specified, but enough information is present to approximate the scenario.
Documented Settings: PSV mode: TV ~300 mL, Pr 12 cmH2O, PEEP 5 cmH2O, RR 14
Commentary: No change in support parameters since March 25, 2024. This long-term stability suggests the patient’s condition is neither deteriorating nor significantly improving toward lower support. The ventilator settings remain consistent, likely indicating chronic stable respiratory failure management.
Weaning from mechanical ventilation—whether invasive (via PSV reduction) or noninvasive (gradual reduction in IPAP/EPAP)—typically requires objective and subjective assessments. Common criteria and indices include:
By November 8, 2024, the patient remains stable on PSV at Pr 12 cmH2O and PEEP 5 cmH2O, with a tidal volume around 300 mL. To assess further weaning potential, it would be advisable to:
No attempts since March 2024 have been documented to reduce support from PSV 12 cmH2O to a lower level or to shift to a simpler mode (e.g., CPAP only) as a step toward extubation or liberation from mechanical ventilation.
For future monitoring, it would be prudent to consider:
If the patient tolerates reduced support (e.g., PSV 10 cmH2O or even transitioning to CPAP or minimal support), it may indicate readiness to attempt complete weaning or prolonged noninvasive support only (e.g., BiPAP at home if considered appropriate).
The Rapid Shallow Breathing Index (RSBI) is a clinical parameter used to assess the likelihood of successful weaning from mechanical ventilation. It relates a patient’s respiratory rate (RR) to their tidal volume (Vt), providing insight into respiratory efficiency and effort.
\[ \text{RSBI} = \frac{\text{Respiratory Rate (RR)}}{\text{Tidal Volume (Vt in liters)}} \]
If you must use VTi:
\[ \text{RSBI} = \frac{15}{0.35} \approx 42.9 \]
An RSBI of about 42.9 is well below the commonly accepted threshold of 105, suggesting that the patient may be ready to begin weaning from mechanical ventilation.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on Decmeber 11, 2024
Mechanical ventilation modes such as Synchronized Intermittent Mandatory Ventilation (SIMV) allow both mandatory (ventilator-driven) and spontaneous (patient-driven) breaths. Clinicians often use pressure-based settings to control or support these breaths. However, handwritten and device-displayed ventilator settings can sometimes differ in terminology, causing confusion about parameters like IP (Inspiratory Pressure) and SP (Pressure Support). This document clarifies these terms and illustrates how they translate across different devices.
A frequently encountered example is a handwritten note reading:
SIMV | O2 2L | RR 16 | IP 8 | SP 8 | PEEP 5
1. SIMV
Synchronized Intermittent Mandatory Ventilation, a mode where a set number of breaths are delivered by the ventilator at a preset level, while allowing spontaneous breathing in between.
2. O2 2L
Represents an oxygen flow of 2 L/min. Depending on the ventilator model, this may correlate to a specific FiO₂ (Fraction of Inspired Oxygen).
3. RR 16
A mandatory breath rate of 16 breaths per minute.
4. IP 8 → "P control"
Often shorthand for Inspiratory Pressure (in pressure-controlled or assisted modes). In many SIMV modes, “IP” may be the pressure above PEEP delivered during each mandatory breath.
5. SP 8 → "PS"
Common shorthand for Pressure Support for spontaneous breaths. Helps reduce work of breathing by assisting patient-initiated breaths with an additional 8 cmH₂O of pressure.
6. PEEP 5
Positive End-Expiratory Pressure of 5 cmH₂O, preventing alveolar collapse at end-expiration and improving oxygenation.
In this handwritten example, both the mandatory breaths (IP 8) and spontaneous breaths (SP 8) receive a similar pressure level (8 cmH₂O above PEEP).
Later, the ventilator settings were checked on a ResMed device, which displayed:
Parameter | Value | Notes |
---|---|---|
Mode | P-SIMV | Pressure-Synchronized Intermittent Mandatory Ventilation. |
PC | 8.0 cmH₂O | Pressure Control, essentially the same concept as Inspiratory Pressure (IP). |
PEEP | 5.0 cmH₂O | Positive End-Expiratory Pressure. |
RR | 16 breaths/min | Number of mandatory breaths per minute. |
Ti | 1.20 seconds | Inspiratory time for each mandatory (ventilator-driven) breath. |
PS | 8 cmH₂O | Pressure Support, applied to spontaneous (patient-initiated) breaths. |
Rise Time | 200 ms | The duration it takes the ventilator to reach the set pressure. |
In this scenario:
Inspiratory Pressure (IP) / Pressure Control (PC)
Refers to the preset pressure for mandatory breaths. In pressure-controlled SIMV, the ventilator ensures each mandatory breath reaches this target pressure above PEEP.
Pressure Support (PS)
Augments spontaneous breaths initiated by the patient. Eases the patient’s work of breathing by providing extra pressure, helping overcome airway resistance and ventilator circuit resistance.
Ventilator settings vary based on patient condition, but the following ranges serve as general guidelines:
Parameter | Typical Range | Clinical Considerations |
---|---|---|
FiO₂ (or O₂ Flow) | 21–100% FiO₂ 2–15 L/min (if flow-based) |
Adjusted to achieve target oxygen saturation (e.g., SpO₂ ≥ 92%). |
Respiratory Rate (RR) | 10–20 breaths/min (can be 8–30) | Titrated based on blood gas analyses, pH, PaCO₂, etc. |
PEEP | 4–10 cmH₂O (sometimes 10–15 cmH₂O+ in ARDS or severe hypoxemia) |
Improves oxygenation by preventing alveolar collapse. |
Pressure Control (PC/IP) | 8–25 cmH₂O above PEEP | Lower levels (≈8–10 cmH₂O) for minimal support; higher for severe cases. |
Pressure Support (PS) | 5–15 cmH₂O | Chosen based on work of breathing and patient comfort. |
Inspiratory Time (Ti) | ~0.8–1.5 seconds | Ensures adequate tidal volume without causing air trapping. |
Rise Time | 50–300 ms | Affects how quickly pressure is delivered; personalized per patient. |
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on February 25, 2025
A patient with a prior stroke secondary to arrhythmia initially received anticoagulant therapy, followed by a hemorrhagic stroke, which required neurosurgical intervention. After an extended hospitalization (~140 days) with persistent deep drowsiness, the patient was transferred to the current facility on March 21, 2025 for continued neurological care, infection control, and ventilator weaning.
The patient has a tracheostomy with a T-tube (size 7.0). An auto-suction line—a specialized, often closed, suction system designed to reduce circuit breaks and minimize infection risk—is available. However, it is not currently used because previous episodes of aspiration pneumonia coincided with mealtime and feeding, leading the care team to opt for manual suctioning and more controlled airway management techniques.
The patient is managed using PSIMV (Pressure Synchronized Intermittent Mandatory Ventilation) with Pressure Support (PS) for spontaneous breaths. A Pressure Control (PC) backup ensures a minimum mandatory ventilation if the patient’s spontaneous rate or effort becomes insufficient.
Weaning Approach: In this mode, the focus is on gradually reducing Pressure Support. For example, from 10 cmH₂O to 8 cmH₂O, and then to 5 cmH₂O, provided the patient maintains adequate ventilation and stable vital signs.
Parameter | Current Setting | Typical/Normal Range | Target / Rationale |
---|---|---|---|
Ventilator Mode | PSIMV (ResMed) | N/A | Main mode for partial support; PC acts as backup |
Pressure Control (backup) | 10 cmH₂O | 8–20 cmH₂O (varies by lung condition) | Reduce if the patient consistently meets spontaneous ventilation |
Pressure Support (PS) | 10 cmH₂O | 5–15 cmH₂O | Key for weaning; decrement as tolerated |
PEEP | 5 cmH₂O | 5–10 cmH₂O | Maintain end-expiratory lung volume; can adjust for oxygenation |
Set Respiratory Rate | 12 breaths/min | 12–20 breaths/min (adult) | Ensures a minimal backup rate |
Measured Tidal Volume (Vti) | ~360 mL (0.36 L) | ~6–8 mL/kg PBW1 (≈400–600 mL) | Monitor for adequate alveolar ventilation |
Supplemental O₂ | 3 L/min (nasal cannula) | 1–6 L/min | Aim for SpO₂ ≥ 92% |
1 PBW = Predicted Body Weight
Lower PS from 10 cmH₂O to 8 cmH₂O, and subsequently to 5 cmH₂O if tolerated. Evaluate respiratory rate, tidal volume, oxygen saturation, and overall work of breathing.
Arterial Blood Gas Analysis (ABGA) remains the gold standard for assessing PaCO₂, PaO₂, and pH during weaning trials. If ABGA is not immediately available, rely on:
Continue the antibiotic regimen until clinical and radiological resolution of pneumonia. Optimize enteral feeding (600–900 mL/day) to maintain adequate nutrition without exacerbating respiratory effort or aspiration risk.
The patient’s husband remains the primary caregiver. Ongoing discussions about the risks, benefits, and timeline of ventilator weaning are essential to maintain trust and realistic expectations.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 21, 2025
A patient has been transferred with a ventilator set to ACMV-PC (Assist-Control Mandatory Ventilation in Pressure Control) mode. The transfer document lists specific settings—PEEP 6 cmH₂O, Pi 10 cmH₂O, Rate 14 breaths/min, Ti 1.1 seconds, and a High Trigger—which invite a detailed examination of each parameter and a broader discussion comparing ACMV-PC to ResMed’s P(A)CV and P(A)C modes. The following sections provide a structured overview of these settings, their typical clinical ranges, and the rationale behind assist-control ventilation.
Mode | ACMV-PCV | ||
---|---|---|---|
PEEP | 6 cmH₂O | Pi | 10 cmH₂O |
Ti | 1.1 sec | Rate (bpm) | 14 |
Trigger | High |
The table below aligns the provided settings from the transfer document with typical clinical ranges used in practice. While these values are generally appropriate for many adult patients, they must be adjusted based on individual factors such as lung compliance, oxygenation requirements, and the patient’s spontaneous breathing effort.
Parameter | Provided Setting | Typical Range / Notes |
---|---|---|
PEEP | 6 cmH₂O | Commonly 5–15 cmH₂O (can be higher in ARDS). Maintains alveolar recruitment. |
Pi (Peak Inspiratory Pressure) | 10 cmH₂O | Often 10–20 cmH₂O (adjusted for lung compliance). Affects tidal volume and ventilation. |
Rate (RR) | 14 breaths/min | Typically 12–20 breaths/min for an adult. Set to ensure minimum ventilation. |
Ti (Inspiratory Time) | 1.1 seconds | Usually 0.8–1.2 seconds (adjusted per patient). Influences oxygenation and comfort. |
Trigger | High | Reflects ventilator sensitivity. High = reduced auto-trigger but requires stronger patient effort. |
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 27, 2025
A 90-year-old male patient was transferred with the following ventilator document entry:
Ventilator Transfer Document
- PC/AC → P(A)CV
- Frequency (set): 26 → RR
- Tidal Volume: 400 mL
- PEEP: 4 cmH₂O
- I:E Ratio: 1:1.9
- Inspiration Time: 0.8 seconds
↑ Settings ↑
↓ Measurements ↓
- VTi: 403 mL
- Minute Volume: 11.2 L/min
- Peak Pressure (Ppeak): 22.4 cmH₂O
The document includes both settings (e.g., pressure control, respiratory rate, PEEP) and monitored values (e.g., measured tidal volume, minute volume, peak pressure). The following outline explains each parameter, discusses the equivalent mode on a ResMed ventilator, and provides a table of typical normal ranges to guide clinical decision-making.
The list includes both configuration settings and measurements:
The following table provides general reference ranges. Actual targets must be tailored to each patient’s clinical condition, including lung mechanics, gas exchange requirements, and comorbidities.
Parameter | Typical Normal Range | Remarks |
---|---|---|
Respiratory Rate | 12–20 breaths/min | Can be higher (up to 20–30) if the patient requires increased ventilation (e.g., to correct hypercapnia). |
Tidal Volume | 6–8 mL/kg of predicted body weight | Often 400–600 mL in adults; focus on lung-protective ventilation to avoid volutrauma. |
PEEP | 5–10 cmH₂O | Typically started around 5 cmH₂O; titrate to improve oxygenation and prevent alveolar collapse. |
I:E Ratio | 1:2 (range 1:1.5–1:4) | Adjusted based on pathology (e.g., COPD may require prolonged expiration). |
Inspiratory Time | 0.8–1.2 seconds | Depends on desired I:E ratio and specific disease factors. |
Minute Ventilation | 5–10 L/min | Varies with metabolic demands; measured to ensure adequate CO₂ clearance. |
Peak Pressure | < 30 cmH₂O | Peak pressures above 30 cmH₂O may increase lung injury risk; must consider plateau pressure for more accuracy. |
When transferring these parameters to a ResMed ventilator, the following approach is recommended:
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 27, 2025
This case details a patient diagnosed with hypoxic encephalopathy who presented with myoclonic seizures. Pharmacological management included valproate, levetiracetam, and clonazepam, alongside sedative agents. While overt seizure activity subsided, persistent spasticity and a stuporous mental status remained.
Although the patient could initiate spontaneous breathing, intermittent apnea necessitated prolonged ventilatory support. Consequently, a tracheostomy was performed to secure the airway, maintain adequate ventilation, and mitigate the risk of aspiration. The discussion below concentrates on the ventilator settings reported, the indications for mechanical ventilation, and the rationale behind choosing Pressure Support Ventilation (PSV) over other modes.
Diagnosis
Respiratory Status
Airway Access
The ventilator settings are reported as:
“PSV, Above PEEP 9, PEEP 7, FiO₂ 25%”
The notation “Above PEEP 9, PEEP 7” indicates that the patient receives 9 cm H₂O of Pressure Support (PS) in addition to a Positive End-Expiratory Pressure (PEEP) of 7 cm H₂O. Hence, each inspiratory effort is assisted by 9 cm H₂O on top of the 7 cm H₂O baseline. The fraction of inspired oxygen (FiO₂) is set at 25%, suggesting a comparatively low supplemental oxygen requirement.
Patient’s Ventilator Settings | Value | Approximate Range |
---|---|---|
Ventilation Mode | PSV | |
Pressure Support (Above PEEP) | 9 cm H₂O | 5–20 cm H₂O |
PEEP | 7 cm H₂O | 5–10 cm H₂O |
FiO₂ | 25% | 21–100% (adjusted per ABG results) |
Mechanical ventilation was mandated based on neurologic compromise and respiratory insufficiency. In general, mechanical ventilation is considered when specific clinical or numerical thresholds are met:
Indication | Typical Criteria/Threshold |
---|---|
Apnea or Impending Respiratory Arrest | Absent or severely depressed respiratory drive |
Hypoxemia | PaO₂ < 60 mmHg on FiO₂ ≥ 0.50 |
Hypercapnia with Respiratory Acidosis | PaCO₂ > 50 mmHg and pH < 7.25 |
Inability to Protect the Airway | Diminished consciousness, high risk of aspiration |
Ventilatory Muscle Fatigue & Elevated Work of Breathing | RR > 35 breaths/min, rapidly rising PaCO₂ |
Neurological Factors | Severe stupor, inability to maintain consistent ventilatory effort (e.g., GCS < 8, repeated apnea episodes) |
In this patient:
A variety of modes—such as SIMV (Synchronized Intermittent Mandatory Ventilation) PC + PS, PSV, and BiPAP (Bilevel Positive Airway Pressure)—were assessed. Each mode differs in its level of control, synchronization, patient comfort, and reliance on spontaneous effort.
Parameter | SIMV PC + PS | PSV | BiPAP |
---|---|---|---|
Level of Control | Mandatory PC breaths + partial support | Patient-driven, pressure-supported breaths | Two-level (inspiratory/expiratory) pressure |
Backup Ventilation | Yes (preset mandatory rate) | No guaranteed rate | Limited (usually noninvasive) |
Patient Effort Required | Moderate | High (patient determines RR & VT) | Moderate to high (depends on mask seal) |
Weaning Potential | Good (can gradually reduce mandatory rate) | Very good (encourages spontaneous effort) | Generally used for noninvasive or mild cases |
Suitability for Altered Mental Status | Moderate (requires patient triggering for additional breaths) | Good if patient can trigger consistently | Less optimal if severe alteration or tracheostomy needed |
Key Advantages | Guarantees a minimum ventilation | Excellent synchrony & comfort, easier weaning | Noninvasive option for less severe cases |
Key Limitations | Possible dyssynchrony if sedation is off | No mandatory minimum ventilation | Not suitable for high apnea risk or severe consciousness depression |
Why PSV for This Patient?
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 28, 2025
A 47-year-old woman with metastatic cerebral carcinoma developed marked tachypnoea (43–48 breaths min⁻¹) and apparent ventilator asynchrony after an episode of regurgitation while receiving pressure-controlled ventilation. This report summarises the clinical findings, analyses the potential mechanisms of patient–ventilator dyssynchrony, and proposes a structured, evidence-based management algorithm. The discussion emphasises protective ventilation, airway protection, neurocritical-care goals, and the importance of waveform analysis.
Variable | Observed value | Usual target / reference | Comment |
---|---|---|---|
Age / sex | 47 y, female | – | Glioblastoma with extracranial metastasis |
Cancer stage | IV (cerebral) | – | Palliative intent |
Airway | Cuffed ETT, ↓gag reflex post-regurgitation | Secured, cuff pressure 20–30 cmH₂O | High aspiration risk |
Core temperature | 37.7 °C | 36–37.5 °C | Mild pyrexia |
Set ventilator mode | P-control + pressure support | Mode choice dependent on lung mechanics | Hybrid settings |
Set P_control | 8 cmH₂O | 12–18 cmH₂O (ARDSnet low-VT) | Likely insufficient |
Set pressure support | 8 cmH₂O | 8–12 cmH₂O | Acceptable |
Set respiratory rate | 20 min⁻¹ | 16–20 min⁻¹ | Protective target |
Measured RR | 43–48 min⁻¹ | 16–24 min⁻¹ | Severe tachypnoea |
SpO₂ | (not provided) | ≥ 94 % (brain injury) | Must be confirmed |
PaCO₂ (ABG) | (awaiting) | 35–45 mm Hg | Needed to guide ICP |
The bar chart below illustrates the disparity between the programmed and observed respiratory rates, highlighting probable trigger asynchrony.
Step | Action | Rationale |
---|---|---|
1 | Increase inspiratory pressure (P_control) by 2–4 cmH₂O increments, targeting Vᴛ 6 ml kg⁻¹ IBW | Reduces respiratory drive, improves alveolar ventilation |
2 | Adjust trigger sensitivity (flow 1–2 L min⁻¹ or pressure –1 cmH₂O) | Minimises ineffective triggering |
3 | Prolong inspiratory time (Tᵢ) or use pressure-controlled assist/control to synchronise cycling | Avoids double-triggering |
4 | Titrate pressure support (8 → 12 cmH₂O) if switching to PSV mode | Off-loads work of breathing |
5 | Optimise sedation-analgesia (e.g., fentanyl + propofol; consider dexmedetomidine for neuro-ICU) | Blunts excessive drive |
6 | If refractory, trial neuromuscular blockade (short-acting) while correcting underlying trigger | Temporarily abolishes dyssynchrony |
7 | Re-evaluate ABG 30 min after each major change; target PaCO₂ 35–40 mm Hg and PaO₂ ≥ 80 mm Hg | Maintains cerebral perfusion pressure |
8 | Initiate aspiration prophylaxis: broad-spectrum antibiotics if infiltrates + sepsis markers | Treats secondary infection |
9 | Implement lung-protective strategy: PEEP titration per driving pressure or FiO₂–PEEP tables | Prevents VILI |
10 | Escalate to volume-controlled ventilation or closed-loop mode (e.g., iVAPS) if control remains poor | Provides consistent Vᴛ |
Trigger type | Recommended range | Typical setting |
---|---|---|
Flow trigger | 1–3 L/min | 2 L/min |
Pressure trigger | –0.5 to –2 cmH₂O | –1 cmH₂O |
Ventilator mode | Absolute Tᵢ | I:E ratio |
---|---|---|
Volume-controlled | 0.8–1.2 s | 1:2 to 1:3 (≈25–33%) |
Pressure-controlled | 0.8–1.0 s | Ti% ≈ 30–35% |
Setting | Adjustment | Purpose |
---|---|---|
Trigger sensitivity |
Lower threshold (↑ sensitivity)
|
|
Inspiratory time | Maintain within above ranges; adjust Ti% based on drive and mechanics |
|
|<--- Insp. (30%) --->|<------ Exp. (70%) ------>|
Note: Excessive sensitivity may lead to auto-triggering (e.g., from circuit noise or cardiac oscillations). Fine adjustments guided by waveform inspection are advised.
Protective ventilation in brain-injured oncology patients requires a balance between minimising ventilator-induced lung injury and avoiding secondary cerebral insults. Hypoxaemia and hypercapnia both augment cerebral blood flow and raise ICP; conversely, excessive hyperventilation may cause cerebral vasoconstriction and ischaemia. The observed tachypnoea likely reflects inadequate tidal volume delivery and a strong central drive, compounded by agitation and airway irritation after regurgitation.
Pressure control of 8 cmH₂O typically yields Vᴛ < 4 ml kg⁻¹ in most adults, insufficient for CO₂ clearance. Gradual increments, combined with careful waveform analysis, improve synchrony without abrupt ICP shifts. Sedation using agents with minimal ICP impact (propofol, dexmedetomidine) helps dampen excessive respiratory drive. Neuromuscular blocking agents should remain a rescue strategy given deleterious effects on neurological assessment.
Empirical antibiotics are justified when aspiration is likely and temperature rises; however, fever alone (37.7 °C) warrants cultures before escalation. Early bronchoscopy clears obstructive debris, reducing ventilator demands.
This manuscript has been proof-read and formatted for clarity. Figures and tables are included to aid comprehension.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on May 1, 2025
A patient initially managed on Pressure Support Ventilation (PSV) with a Positive End-Expiratory Pressure (PEEP) of 5 cm H₂O and Pressure Support (PS) of 10 cm H₂O was transitioned to Synchronized Intermittent Mandatory Ventilation (SIMV) mode due to an episode of apnea. The new ventilator settings included PEEP 5 cm H₂O, Respiratory Rate (RR) 12 breaths per minute, and Inspiratory Pressure (IP) 5 cm H₂O. Subsequent arterial blood gas analysis (ABGA) revealed mild acidosis with a partial pressure of carbon dioxide (PaCO₂) at 55 mmHg, oxygen saturation (SpO₂) at 100%, and a reduction in FiO₂ from 0.6 to 0.4.
Primary Concern: Elevated PaCO₂ levels necessitate adjustments to the ventilatory strategy to enhance alveolar ventilation and mitigate respiratory acidosis.
Rationale: Augmenting RR directly increases minute ventilation (MV = RR × Tidal Volume [TV]), facilitating greater elimination of CO₂.
Considerations:
Rationale: Enhancing TV increases MV, thereby promoting CO₂ clearance.
Implementation:
Considerations:
If TV is Adequate:
If TV is Inadequate:
Switch to Assist-Control (AC) Mode if Apnea Persists:
Evaluate Necessity of Sedation:
Investigate Underlying Causes of Apnea:
Transition to Pressure Control (PC) Mode for Respiratory Muscle Rest:
When using a pneumatic jet nebulizer in respiratory therapy, it's crucial to consider its impact on mechanical ventilation parameters. (1) First, introducing a jet nebulizer can significantly increase the flow within the ventilatory circuit, which in turn may inadvertently raise the tidal volume (TV) delivered to the patient. This increase can lead to unexpectedly high lung volumes, risking volutrauma if not closely monitored and adjusted. (2) Additionally, this extra flow can cause a slight increase in airway pressure. While generally mild, this increase requires careful monitoring to prevent potential adverse effects on patients with compromised lung function or those at risk of barotrauma.
(3) Another consideration is the effect on the fraction of inspired oxygen (FiO2). The use of a jet nebulizer can dilute the oxygen concentration within the ventilatory circuit as air is utilized to nebulize the medication, resulting in a reduced FiO2. Adjusting the oxygen settings to compensate for this dilution is essential to ensure that the desired level of oxygenation is maintained. (4) Furthermore, the additional flow and pressure fluctuations introduced by the nebulizer can interfere with the ventilator's sensitivity settings, complicating the initiation of spontaneous breathing by the patient. This may increase the work of breathing and lead to discomfort or fatigue. To mitigate these effects, it may be necessary to adjust the trigger sensitivity settings on the ventilator to lower the threshold required for triggering, thereby reducing the respiratory effort needed from the patient.
High Airway Pressure (Paw) Alarm: This alarm can be triggered by increased airway resistance or decreased lung compliance. To reduce airway resistance, perform suctioning and administer nebulized treatments. If the issue is related to lung compliance, consider interventions such as inhaled nitric oxide or extracorporeal membrane oxygenation (ECMO) to enhance lung flexibility and functionality.
Decreased Oxygen Saturation: When decreased oxygen saturation is detected, indicated by alarms or monitoring systems, several critical steps must be taken to ensure optimal patient care. Oxygen levels are primarily monitored using SpO2 and arterial oxygen partial pressure (PaO2). Immediate actions include resolving any High Paw Alarm by suctioning and nebulization to decrease airway resistance. It is also vital to thoroughly check the ventilatory circuit for any disconnections or leaks, as these can significantly compromise the oxygen delivery system.
To assess the patient's oxygenation status more comprehensively, performing an arterial blood gas analysis (ABGA) is recommended to check PaO2 levels. Based on these results, adjustments to the fraction of inspired oxygen (FiO2) and positive end-expiratory pressure (PEEP) should be considered. Initially, FiO2 may be increased to deliver more oxygen, especially in acute settings. Concurrently, adjusting PEEP can help improve oxygenation and ensure the patient receives adequate oxygen while preventing potential lung damage.
A practical approach involves starting with higher FiO2 and PEEP settings and then gradually reducing them as the patient's condition stabilizes or improves. For example, beginning with an FiO2 of 100% paired with a PEEP of 12 cm H2O, and methodically lowering both to potentially an FiO2 of 30% and a PEEP of 5 cm H2O as the patient's oxygenation status allows. This systematic and intuitive adjustment process is aligned with the ARDSnet protocol guidelines, which provide extensive tables and further recommendations for managing FiO2 and PEEP in different clinical scenarios.
High Carbon Dioxide Levels (PaCO2): If this alarm activates, first assess whether increased airway resistance is contributing to inadequate CO2 removal. To enhance CO2 clearance, adjust the tidal volume (TV) upwards. Increasing the respiratory rate (RR) can also help by augmenting the overall ventilation. Another strategy is to modify the inspiratory to expiratory ratio (I:E Ratio), which can improve ventilation efficiency. However, care must be taken to ensure that these adjustments do not lead to air trapping, especially in patients with conditions like Chronic Obstructive Pulmonary Disease (COPD).
PEEP High Alarm Due to Filter Obstruction: A 'PEEP High Alarm' in mechanical ventilation typically signals a blockage in the expiratory phase, often due to a clogged filter that impedes the flow of expired air, leading to increased end-expiratory pressure. The crucial step in troubleshooting is to promptly remove the filter to check if it is the source of the obstruction. If removing the filter resolves the alarm and normal ventilation function is restored, this confirms the filter as the culprit. The immediate replacement of the obstructed filter is critical to maintain unimpeded airflow, ensuring the ventilation system operates efficiently and safely.
Management of Expiratory Filters: Expiratory filters are critical in managing airway resistance within mechanical ventilation systems. These filters usually last one to two days, though high-quality, genuine filters can remain effective for up to five days under ideal conditions. Obstructions in these filters are common and can be caused by various factors, including the administration of specific medications such as colistin and coagulants, or due to excessive nebulization. When filter issues are suspected, such as after administering colistin, it is advisable to perform routine checks and ensure timely maintenance or replacement of the filters to maintain optimal ventilation management.
Strategic Use of PEEP in Patients with V/Q Mismatch and Shunting: For patients exhibiting V/Q mismatch or shunting, often caused by lung infiltration as indicated by a chest X-ray, increasing the positive end-expiratory pressure (PEEP) can enhance their condition by improving oxygenation and reducing shunt effects. However, if the PEEP exceeds 10 cm H2O, it may lead to decreased venous return, potentially resulting in hemodynamic instability. In such scenarios, administering an inotrope may be necessary to help maintain or increase blood pressure.
Auto-PEEP Detection and Management (Version I): Auto-PEEP is a significant concern, particularly in patients receiving medications such as colistin or anticoagulants, which can increase the risk of this complication. Monitoring the end-expiratory flow, known as V̇ee on a Servo ventilator, is critical because an increase in V̇ee may indicate the presence of Auto-PEEP, necessitating prompt assessment and intervention to ensure optimal ventilator function and patient safety.
Effective management of Auto-PEEP includes adjusting the inspiratory to expiratory (I:E) ratio, for example, from 1:2 to 1:3. This adjustment extends the expiratory time relative to the inspiratory time, aiming to provide sufficient expiratory time — ideally more than three times the time constant (Tc). This strategy promotes complete exhalation, prevents lung overdistension, optimizes respiratory mechanics, and aids in preventing complications such as air trapping while ensuring efficient CO2 removal. Maintaining the inspiratory time (Ti) within 0.6 to 1.2 seconds, even when altering the I:E ratio, is essential to avoid negative impacts on the patient's breathing pattern.
In scenarios where there is a rapid increase in respiratory rate (RR), continuous monitoring of V̇ee through the "Trends" function on the ventilator is essential. This allows clinicians to observe changes over time and make informed decisions about ventilatory adjustments. Additionally, performing an arterial blood gas analysis (ABGA) is routine to check for CO2 retention and decreased O2 levels, further informing the adjustment process.
Further strategies to manage Auto-PEEP include ensuring clear airways and, if necessary, adjusting the respiratory rate (RR) and tidal volume (TV). Encouraging patients to take deep breaths can help decrease the buildup of intrinsic PEEP and facilitate better lung decompression. Additionally, adjunctive therapies such as nebulization, the administration of steroids, or bronchoscopy may be necessary to address underlying respiratory issues contributing to Auto-PEEP.
Air Trapping Indicators and Management (Version II): Air trapping, commonly seen in conditions like COPD, asthma, or airway edema, manifests through several indicators:
Air Flow Reductions: In scenarios where there is inspiratory pressure but the airflow drops to zero, urgent assessment and management are crucial to identify and rectify underlying causes. This issue often points to problems with lung compliance or mechanical impediments in the ventilation system. Evaluating lung elasticity is essential, and it's important to ensure that inspiratory pressures are not excessively high, as this could exacerbate lung stiffness and compromise function.
In terms of mechanical causes, obstructions in the endotracheal tube (ET tube) should be checked. Such obstructions can be due to kinking, blockage within the tube, or from the patient biting the tube. Inspecting and, if necessary, replacing the ET tube is crucial. If the patient is biting the tube, using a bite block can prevent occlusion and ensure continuous airflow. Addressing these issues promptly is vital not only to restoring proper airflow but also to preventing potential lung damage from inadequate ventilation.
Additionally, understanding lung compliance through static and dynamic indices can provide insights into lung health and guide appropriate ventilatory support. Static Compliance (Cstat) is calculated from the formula VTe / Pplat - PEEP, where VTe is the exhaled tidal volume, Pplat is the plateau pressure after an inhalation pause, and PEEP is the positive end-expiratory pressure, with normal values ranging from 60 to 100 ml/cm H2O. A value below this range indicates increased lung stiffness. Dynamic Compliance (Cdyn), calculated as VTe / EIP - PEEP, where EIP is the end-inspiratory pressure, typically ranges from 50 to 80 ml/cm H2O. Values below 30 ml/cm H2O suggest severe lung conditions such as Acute Respiratory Distress Syndrome (ARDS). Monitoring these indices helps in fine-tuning ventilatory settings to optimize patient care and outcomes.
Measures lung compliance without the influence of airway resistance.
Cstat = VT / (Pplat − PEEP)
Where Pplat is Plateau Pressure and PEEP is Positive End-Expiratory Pressure.
Dynamic compliance is measured during airflow and includes resistance.
Cdyn = VT / (Ppeak − PEEP)
Where Ppeak is Peak Inspiratory Pressure and PEEP is Positive End-Expiratory Pressure.
SIMV-PCV-PS is a ventilator mode that integrates Synchronized Intermittent Mandatory Ventilation (SIMV), Pressure Control Ventilation (PCV), and Pressure Support (PS). This configuration ensures that the ventilator delivers a set number of mandatory breaths at a predetermined pressure as defined by PCV. These breaths are synchronized with any spontaneous efforts by the patient, maintaining necessary ventilation support even in the absence of patient-initiated breathing.
In this mode, if the patient initiates a spontaneous breath, the ventilator shifts to Pressure Support (PS) mode. PS applies a consistent pressure during these spontaneous breaths, facilitating easier breathing by reducing the effort needed to inhale. If no spontaneous efforts occur, the ventilator continues with mandatory PCV breaths, providing uninterrupted support. Therefore, PS is only active during patient-initiated breathing; otherwise, ventilation defaults to the controlled settings of PCV.
High Flow Nasal Cannula (HFNC) therapy is increasingly recognized in modern respiratory care for its ability to deliver heated and humidified medical gas at high flows through a nasal cannula. This advanced respiratory support technique offers significant improvements over traditional low-flow systems (LFNC), which typically provide only up to 6 liters per minute, achieving maximum FiO2 levels of around 0.37 to 0.45. Although systems such as the 8-10L oxygen reservoir mask can deliver FiO2 levels of up to 80% or more, HFNC is preferred for its capability to provide up to 100% humidified and heated oxygen at flow rates reaching 60 liters per minute. This feature ensures a stable fraction of inspired oxygen (FiO2), even amid changing patient demands or respiratory patterns, effectively addressing a key limitation of traditional oxygen therapy methods like wall oxygen with a reservoir mask, which cannot guarantee stable FiO2 during flow changes.
HFNC significantly enhances oxygenation and ventilation by delivering air at rates that exceed a patient's physiological capacity, effectively addressing the limitations posed by physiological dead space. Typically, dead space accounts for about one-third of the tidal volume, leading to CO2 accumulation and decreased availability of oxygen for diffusion. HFNC uses high flow rates to displace stagnant CO2 with fresh O2, increasing the partial pressure of oxygen (PAO2) and creating a more favorable oxygen diffusion gradient. This mechanism is particularly beneficial for enhancing CO2 clearance and alleviating symptoms of dyspnea, thereby increasing minute ventilation and effectively reducing dead space. These benefits are especially advantageous for patients with chronic obstructive pulmonary disease (COPD), as HFNC therapy eases their work of breathing and improves overall respiratory efficiency.
Additionally, HFNC reduces nasopharyngeal airway resistance by applying positive pressure that dilates the airways. According to the Hagen-Poiseuille law, airway resistance is inversely proportional to the fourth power of the airway radius (R = 8 n l / π r4), meaning that increasing the radius decreases resistance and enhances airflow. This physiological advantage is pivotal in managing respiratory conditions that involve compromised airway dynamics or ineffective air exchange, making HFNC an essential tool in respiratory care. The clinical benefits of HFNC are particularly evident in conditions like acute hypoxemic respiratory failure and COPD exacerbations, where the reduction in airway resistance can improve gas exchange and reduce the work of breathing. In acute settings, the positive airway pressure provided by HFNC helps maintain alveolar stability, enhancing oxygenation and comfort, which is crucial for patient outcomes. Studies such as the FLORALI trial highlight HFNC's role in reducing mortality and increasing ventilator-free days compared to conventional oxygen therapies. Additionally, HFNC's consistent oxygen delivery makes it highly effective for patients during critical pre and post-extubation periods, ensuring optimal respiratory support.
Moreover, the humidification and heating provided by HFNC reduce dryness in the nasal passages and mouth, minimizing gastrointestinal disturbances and the risk of atelectasis by maintaining mucociliary function and airway patency. HFNC's effectiveness extends to neonatal care, providing gentle and appropriate respiratory support for the delicate nature of neonatal airways. This is facilitated by adjustable flow rates from systems like the widely used Airvo, OmniOx and MC FLO HFNC devices, which offer settings ranging from 10 to 60 L/min for adults and 15 to 30 L/min for pediatrics, managed by controlling the flow meter connected to wall oxygen.
However, HFNC is not without potential drawbacks. It can lead to excessive CO2 reduction, potentially suppressing the respiratory drive if not carefully monitored. The therapy may also increase expiratory resistance, leading to an inadvertent continuous positive airway pressure (CPAP) effect that could elevate airway pressures and result in complications such as barotrauma, volutrauma, and pneumothorax. Additionally, the possibility of patients adjusting or removing the nasal cannula can create stability issues and compromise the delivery of precise FiO2. In scenarios of severe respiratory failure where higher levels of support are necessary, traditional mechanical ventilation may be required. This includes situations necessitating intubation and invasive ventilation to manage higher pressures safely and effectively, highlighting HFNC's limitations in more critical care scenarios.
Amato, M. B. P. et al. (2015). Driving pressure and survival in the acute respiratory distress syndrome. The New England Journal of Medicine, 372(8), 747-755. https://doi.org/10.1056/NEJMsa1410639
ARDSnet. (2008, July). Mechanical Ventilation Protocol Summary. NIH NHLBI ARDS Clinical Network. View Protocol.
Cairo, J.M. (2023). Pilbeam's Mechanical Ventilation: Physiological and Clinical Applications (8th ed.). Elsevier.
Tobin, M. J. (Ed.). (2013). Principles and Practice of Mechanical Ventilation (3rd ed.). McGraw-Hill Education.
The Acute Respiratory Distress Syndrome Network. (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England Journal of Medicine, 342(18), 1301-1308. https://doi.org/10.1056/NEJM200005043421801
Check out the YouTube channel LOVmediteck for more information.
Note: The exact naming conventions and parameter options may vary by device or manufacturer. While these settings typically apply to ResMed devices that offer an (A)C or Volume Control mode, be sure to verify with the official device manual or manufacturer guidelines to confirm the specific parameters available on a particular model.